Public company info
Input the stock code or the company name     Search  
 


 Stock code   01228 
 Company name  CANbridge Pharmaceuticals Inc.
 Region  Hong Kong
 Type  MB
 Website  
 Quote  0.0 

Company profile  |  Business review  |  Prospect  |  Latest results  |  Financial ratios
Income statement  |  Cash flow statement  |  Balance sheet  |  Entitlement
Disclosure of interest  |  Quote

 Related stock news
  《業績》北海康成扭虧全年賺1,482...  2026-03-31T  
  北海康成折讓14.7%配股予藥明生物...  2026-02-16T  
  北海康成創新藥CAN 103獲納入商...  2025-12-08T  
  北海康成折讓19.86%發新股 籌淨...  2025-09-15T  
  《業績》北海康成半年虧轉盈賺5,92...  2025-09-01T  
  《復牌》北海康成向百洋醫藥發新股集資...  2025-08-12T  
  北海康成短暫停牌 待刊發內幕消息公告  2025-08-12T  
  北海康成藥物戈芮寧獲國家藥監局批准上...  2025-05-20T  
  《業績》北海康成全年虧損擴至4.43...  2025-04-01T  
  北海康成-B變更核數師  2024-12-06T  
  Search   More 
 Latest News
  銳科激光：公司LD直接泵浦近基模萬瓦...  2026-08-18T15:  
  普利特：目前公司LCP纖維在上述領域...  2026-08-18T15:  
  Search   More 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.